1 As of 2025, roughly 10 million Americans 2 are on GLP-1s, for both treatment of type 2 diabetes and weight loss, and that number is expected to reach 25 million by 2030
A study presented at an American Heart Association conference in 2024 found that people who followed time-restricted eating were 91% more likely to die of cardiovascular disease than those on a typical diet
GLP-1 agonists, or glucagon-like peptide-1 receptor agonists, represent a class of medications primarily used to manage type 2 diabetes and obesity
If we cannot get it, you will be notified and refunded
By sequestering miR-195-5p, circUtrn alleviates its repression of FBXW7 and MFN2 , thereby reducing cardiomyocyte apoptosis, promoting mitochondrial biogenesis, and enhancing energy metabolism
The skin, especially in older adults or those with preexisting volume loss, may not bounce back, leading to a hollow or aged appearance